通用電氣健康部門預測2025年調整後每股收益為4.61至4.75美元，高於市場預期的4.66美元

財報速遞

02-13

今天，公司發佈了2025年全年指引，其中包括了最近實施的美國對中國產品關稅的預估影響。2025年指引如下：

有機收入同比增長2%至3%，反映了對我們產品和服務的持續需求以及對中國市場狀況的謹慎看法
調整後的EBIT利潤率爲16.7%至16.8%，較2024年調整後的EBIT利潤率16.3%擴張了約40至50個基點
調整後的有效稅率（ETR）在22%至23%之間
調整後的每股收益在4.61美元至4.75美元之間，較2024年調整後的每股收益*4.49美元增長3%至6%
自由現金流至少爲17.5億美元

以上內容來自Benzinga Earnings專欄，原文如下：

2025 guidance

Today, the Company introduces 2025 full-year guidance, which includes the estimated impact from recently implemented U.S. tariffs on products from China.

2025 guidance is as follows:

Organic revenue growth of 2% to 3% year-over-year, which reflects continued demand for our products and services as well as a measured view of market conditions in China
Adjusted EBIT margin of 16.7% to 16.8%, reflecting an expansion of approximately 40 to 50 basis points versus 2024 Adjusted EBIT margin of 16.3%
Adjusted effective tax rate (ETR) in the range of 22% to 23%
Adjusted EPS in the range of $4.61 to $4.75, representing 3% to 6% growth versus Adjusted EPS* of $4.49 for 2024
Free cash flow of at least $1.75 billion

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1199081682"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1199081682\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1199081682?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-02-13 19:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199081682","market":"us","top_or_hot":-1,"title":"通用電氣健康部門預測2025年調整後每股收益為4.61至4.75美元，高於市場預期的4.66美元","media":"財報速遞","content":"<html><body><p>今天，公司發佈了2025年全年指引，其中包括了最近實施的美國對中國產品關稅的預估影響。2025年指引如下：\n</p><ul>\n<li>有機收入同比增長2%至3%，反映了對我們產品和服務的持續需求以及對中國市場狀況的謹慎看法</li>\n<li>調整後的EBIT利潤率爲16.7%至16.8%，較2024年調整後的EBIT利潤率16.3%擴張了約40至50個基點</li>\n<li>調整後的有效稅率（ETR）在22%至23%之間</li>\n<li>調整後的每股收益在4.61美元至4.75美元之間，較2024年調整後的每股收益*4.49美元增長3%至6%</li>\n<li>自由現金流至少爲17.5億美元</li>\n</ul><br/><br/>以上內容來自Benzinga Earnings專欄，原文如下：<br/><p><strong>2025 guidance</strong></p><p>Today, the Company introduces 2025 full-year guidance, which includes the estimated impact from recently implemented U.S. tariffs on products from China.</p><p>2025 guidance is as follows:</p><ul><li>Organic revenue growth of 2% to 3% year-over-year, which reflects continued demand for our products and services as well as a measured view of market conditions in China</li><li>Adjusted EBIT margin of 16.7% to 16.8%, reflecting an expansion of approximately 40 to 50 basis points versus 2024 Adjusted EBIT margin of 16.3%</li><li>Adjusted effective tax rate (ETR) in the range of 22% to 23%</li><li>Adjusted EPS in the range of $4.61 to $4.75, representing 3% to 6% growth versus Adjusted EPS* of $4.49 for 2024</li><li>Free cash flow of at least $1.75 billion</li></ul></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>通用電氣健康部門預測2025年調整後每股收益為4.61至4.75美元，高於市場預期的4.66美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n通用電氣健康部門預測2025年調整後每股收益為4.61至4.75美元，高於市場預期的4.66美元\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1048278264\">\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">財報速遞 </p>\n<p class=\"h-time smaller\">2025-02-13 19:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n今天，公司發佈了2025年全年指引，其中包括了最近實施的美國對中國產品關稅的預估影響。2025年指引如下：\n<ul>\n<li>有機收入同比增長2%至3%，反映了對我們產品和服務的持續需求以及對中國市場狀況的謹慎看法</li>\n<li>調整後的EBIT利潤率爲16.7%至16.8%，較2024年調整後的EBIT利潤率16.3%擴張了約40至50個基點</li>\n<li>調整後的有效稅率（ETR）在22%至23%之間</li>\n<li>調整後的每股收益在4.61美元至4.75美元之間，較2024年調整後的每股收益*4.49美元增長3%至6%</li>\n<li>自由現金流至少爲17.5億美元</li>\n</ul><br/><br/>以上內容來自Benzinga Earnings專欄，原文如下：<br/><p><strong>2025 guidance</strong></p><p>Today, the Company introduces 2025 full-year guidance, which includes the estimated impact from recently implemented U.S. tariffs on products from China.</p><p>2025 guidance is as follows:</p><ul><li>Organic revenue growth of 2% to 3% year-over-year, which reflects continued demand for our products and services as well as a measured view of market conditions in China</li><li>Adjusted EBIT margin of 16.7% to 16.8%, reflecting an expansion of approximately 40 to 50 basis points versus 2024 Adjusted EBIT margin of 16.3%</li><li>Adjusted effective tax rate (ETR) in the range of 22% to 23%</li><li>Adjusted EPS in the range of $4.61 to $4.75, representing 3% to 6% growth versus Adjusted EPS* of $4.49 for 2024</li><li>Free cash flow of at least $1.75 billion</li></ul>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GEHC","symbol_name":"GE HEALTHCARE TECHNOLOGIES INC","start_time":0,"source_url":"","article_id":"1199081682","we_media_id":"1048278264","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199081682","pubTimestamp":1739445890,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"財報速遞","introduction":"每日财报追踪","home_visible":1,"id":"1048278264","head_image":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738"},"summary":"今天，公司發佈了2025年全年指引，其中包括了最近實施的美國對中國產品關税的預估影響。調整後的EBIT利潤率為16.7%至16.8%，較2024年調整後的EBIT利潤率16.3%擴張了約40至50個基點。調整後的每股收益在4.61美元至4.75美元之間，較2024年調整後的每股收益*4.49美元增長3%至6%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"GEHC":"GE HEALTHCARE TECHNOLOGIES INC","GE":"GE航空航天"},"translate_title":"GE Health forecasts 2025 adjusted earnings per share of $4.61 to $4.75, ahead of consensus of $4.66","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GE":1,"GEHC":0.9},"content_text":"今天，公司發佈了2025年全年指引，其中包括了最近實施的美國對中國產品關税的預估影響。2025年指引如下：\n\n有機收入同比增長2%至3%，反映了對我們產品和服務的持續需求以及對中國市場狀況的謹慎看法\n調整後的EBIT利潤率為16.7%至16.8%，較2024年調整後的EBIT利潤率16.3%擴張了約40至50個基點\n調整後的有效税率（ETR）在22%至23%之間\n調整後的每股收益在4.61美元至4.75美元之間，較2024年調整後的每股收益*4.49美元增長3%至6%\n自由現金流至少為17.5億美元\n以上內容來自Benzinga Earnings專欄，原文如下：2025 guidanceToday, the Company introduces 2025 full-year guidance, which includes the estimated impact from recently implemented U.S. tariffs on products from China.2025 guidance is as follows:Organic revenue growth of 2% to 3% year-over-year, which reflects continued demand for our products and services as well as a measured view of market conditions in ChinaAdjusted EBIT margin of 16.7% to 16.8%, reflecting an expansion of approximately 40 to 50 basis points versus 2024 Adjusted EBIT margin of 16.3%Adjusted effective tax rate (ETR) in the range of 22% to 23%Adjusted EPS in the range of $4.61 to $4.75, representing 3% to 6% growth versus Adjusted EPS* of $4.49 for 2024Free cash flow of at least $1.75 billion","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":1}}}